“The Garvan-Weizmann Partnership is truly synergistic – an example of a collaboration that is greater than the sum of its parts. It is a collaboration that will positively impact people across the globe in our lifetime.” Jillian Segal AO

Launched in 2016, the Partnership between the Weizmann Institute of Science and Garvan Institute of Medical Research, based in Sydney has harnessed the complementary expertise of these two world-class research institutes through joint programs, staff and student exchange and the use of cutting-edge technologies. This has enabled Weizmann and Garvan scientists to uncover entirely new insights into autoimmune diseases, cancers, type 2 Diabetes and genomics.

The Garvan-Weizmann Partnership is particularly momentous as the Weizmann Institute is a global leader in multidisciplinary basic research and Garvan’s focus is on translational research. Together their complementary strengths enable scientists to answer some of science and medicine’s greatest questions faster than ever before in the areas of biomedical research, genomic medicine and genomic education.